Published in Biomaterials on July 01, 1984
EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis (2008) 4.88
An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum (2000) 3.06
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis (2008) 2.25
The role of hydrated silica, titania, and alumina in inducing apatite on implants. J Biomed Mater Res (1994) 2.25
Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford) (2007) 1.95
Nosocomial transmission of methicillin-resistant Staphylococcus aureus via the surfaces of the dental operatory. Br Dent J (2006) 1.54
Chemical implant fixation using hydroxyl-apatite coatings. The development of a human total hip prosthesis for chemical fixation to bone using hydroxyl-apatite coatings on titanium substrates. Clin Orthop Relat Res (1987) 1.52
Plasma-sprayed coatings of tetracalciumphosphate, hydroxyl-apatite, and alpha-TCP on titanium alloy: an interface study. J Biomed Mater Res (1991) 1.48
[Is methotrexate nephrotoxic? Dose-dependency, comorbidities and comedication]. Z Rheumatol (2011) 1.47
Bioceramics consisting of calcium phosphate salts. Biomaterials (1980) 1.46
A preliminary study on osteoinduction of two kinds of calcium phosphate ceramics. Biomaterials (1999) 1.43
Tissue response to nano-hydroxyapatite/collagen composite implants in marrow cavity. J Biomed Mater Res (1998) 1.42
Histological evaluation of biocompatible orthopaedic polymer. Biomaterials (1990) 1.41
Studies of the solubility of different calcium phosphate ceramic particles in vitro. Biomaterials (1990) 1.35
Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene (2006) 1.32
A finite element analysis of the push-out test: influence of test conditions. J Biomed Mater Res (1992) 1.30
Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release (2004) 1.30
Bonding of bone to apatite-coated implants. J Bone Joint Surg Br (1988) 1.27
Biomimetic calcium phosphate coatings on Ti6AI4V: a crystal growth study of octacalcium phosphate and inhibition by Mg2+ and HCO3-. Bone (1999) 1.26
BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone (2005) 1.24
Study of the surface characteristics of magnetron-sputter calcium phosphate coatings. J Biomed Mater Res (1994) 1.21
Hydroxylapatite/poly(L-lactide) composites: an animal study on push-out strengths and interface histology. J Biomed Mater Res (1993) 1.17
Three-dimensional nano-HAp/collagen matrix loading with osteogenic cells in organ culture. J Biomed Mater Res (1999) 1.17
Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature. Clin Exp Rheumatol (2001) 1.17
Influence of ionic strength and carbonate on the Ca-P coating formation from SBFx5 solution. Biomaterials (2002) 1.16
Biodegradation behavior of various calcium phosphate materials in bone tissue. J Biomed Mater Res (1983) 1.14
Evaluation of hydroxylapatite/poly(L-lactide) composites: mechanical behavior. J Biomed Mater Res (1992) 1.13
Osteointegration of biomimetic apatite coating applied onto dense and porous metal implants in femurs of goats. J Biomed Mater Res B Appl Biomater (2003) 1.13
Incorporation of bovine serum albumin in calcium phosphate coating on titanium. J Biomed Mater Res (1999) 1.12
Biomimetic coprecipitation of calcium phosphate and bovine serum albumin on titanium alloy. J Biomed Mater Res (2001) 1.10
Tissue responses of calcium phosphate cement: a study in dogs. Biomaterials (2000) 1.06
Relationship between temporomandibular joint (TMJ)-related pain and morphological changes of the TMJ condyle in patients with temporomandibular disorders. Dentomaxillofac Radiol (2004) 1.06
Preparation of bioactive Ti6Al4V surfaces by a simple method. Biomaterials (1998) 1.04
Incorporation of growth factors into medical devices via biomimetic coatings. Philos Trans A Math Phys Eng Sci (2006) 1.04
Bone induction by porous glass ceramic made from Bioglass (45S5). J Biomed Mater Res (2001) 1.03
Macropore tissue ingrowth: a quantitative and qualitative study on hydroxyapatite ceramic. Biomaterials (1986) 1.01
X-ray diffraction studies on plasma-sprayed calcium phosphate-coated implants. J Biomed Mater Res (1990) 1.01
In vivo study of calcium phosphate cements: implantation of an alpha-tricalcium phosphate/dicalcium phosphate dibasic/tetracalcium phosphate monoxide cement paste. Biomaterials (1997) 1.01
Formation of calcium phosphate/collagen composites through mineralization of collagen matrix. J Biomed Mater Res (2000) 0.99
Osteoclastic resorption of biomimetic calcium phosphate coatings in vitro. J Biomed Mater Res (2001) 0.98
Characterization of silane-treated hydroxyapatite powders for use as filler in biodegradable composites. J Biomed Mater Res (1996) 0.98
Formation and characteristics of the apatite layer on plasma-sprayed hydroxyapatite coatings in simulated body fluid. Biomaterials (1997) 0.97
Schwannoma in the sublingual space. Dentomaxillofac Radiol (2004) 0.97
Treatment outcome with implant-retained overdentures: Part II--Patient satisfaction and predictability of subjective treatment outcome. J Prosthet Dent (1994) 0.97
A long-term follow-up study of radiographically evident degenerative changes in the temporomandibular joint with different conditions of disk displacement. Int J Oral Maxillofac Surg (2005) 0.97
Biomimetic and electrolytic calcium phosphate coatings on titanium alloy: physicochemical characteristics and cell attachment. Biomaterials (2004) 0.97
Histologic evaluation of the osseous adaptation to titanium and hydroxyapatite-coated titanium implants. J Biomed Mater Res (1991) 0.96
Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium. Biomaterials (2002) 0.96
Tri-calcium phosphate as a bone substitute. J Bioeng (1977) 0.95
Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA). J Immunol Methods (1997) 0.95
Severe relapse of Wegener's granulomatosis during the early postpartum period. Ann Rheum Dis (2006) 0.95
A comparison of bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) implanted in muscle and bone of dogs at different time periods. J Biomed Mater Res A (2006) 0.94
Development of comprehensive disease assessment in systemic vasculitis. Postgrad Med J (2008) 0.94
A simple method for preparing thin (10 microM) histological sections of undecalcified plastic embedded bone with implants. Stain Technol (1988) 0.94
Fast precipitation of calcium phosphate layers on titanium induced by simple chemical treatments. Biomaterials (1997) 0.94
Critical factors in the design of growth factor releasing scaffolds for cartilage tissue engineering. Expert Opin Drug Deliv (2008) 0.93
A novel porous Ti6Al4V: characterization and cell attachment. J Biomed Mater Res A (2005) 0.93
Delivery mode and efficacy of BMP-2 in association with implants. J Dent Res (2007) 0.93
The combined use of endosteal implants and iliac crest onlay grafts in the severely atrophic mandible: a longitudinal study. Int J Oral Maxillofac Surg (1997) 0.93
Dual release of proteins from porous polymeric scaffolds. J Control Release (2006) 0.92
In vitro and in vivo degradation of biomimetic octacalcium phosphate and carbonate apatite coatings on titanium implants. J Biomed Mater Res A (2003) 0.92
Proteins incorporated into biomimetically prepared calcium phosphate coatings modulate their mechanical strength and dissolution rate. Biomaterials (2003) 0.92
MicroRNA expression profiles of human leukemias. Leukemia (2007) 0.92
Biocompatibility and degradation of poly(ether-ester) microspheres: in vitro and in vivo evaluation. Biomaterials (2002) 0.92
A histological and histomorphometrical investigation of fluorapatite, magnesiumwhitlockite, and hydroxylapatite plasma-sprayed coatings in goats. J Biomed Mater Res (1993) 0.91
Flattening of the articular eminence correlates with progressive internal derangement of the temporomandibular joint. Dentomaxillofac Radiol (2000) 0.90
The biocompatibility of hydroxyapatite ceramic: a study of retrieved human middle ear implants. J Biomed Mater Res (1990) 0.90
Application of magnetron sputtering for producing ceramic coatings on implant materials. Clin Oral Implants Res (1993) 0.90
Interaction of biodegradable beta-whitlockite ceramics with bone tissue: an in vivo study. Biomaterials (1985) 0.90
[Traffic accidents in obstructive sleep apnea patients and effect of nasal CPAP treatment]. Nihon Kyobu Shikkan Gakkai Zasshi (1993) 0.90
Evaluation of polylactide monomers in an in vitro biocompatibility assay. Biomaterials (1994) 0.90
Tensile strength of the interface between hydroxyapatite and bone. J Biomed Mater Res (1992) 0.90
Preparation of calcium phosphate coatings on titanium implant materials by simple chemistry. J Biomed Mater Res (1998) 0.90
Comparative histocompatibility testing of seven calcium phosphate ceramics. Biomaterials (1981) 0.89
Induction of immunological tolerance by oral administration of nickel and chromium. J Dent Res (1984) 0.89
Surface modification of nano-apatite by grafting organic polymer. Biomaterials (1998) 0.89
Calcium phosphate formation within sol-gel prepared titania in vitro and in vivo. J Biomed Mater Res (1993) 0.88
Deproteinized cancellous bovine bone (Bio-Oss) as bone substitute for sinus floor elevation. A retrospective, histomorphometrical study of five cases. J Clin Periodontol (2003) 0.88
[Generalized lymphadenitis associated with Hashimoto's thyroiditis]. Dtsch Med Wochenschr (2007) 0.88
[Therapy of vasculitides and vasculopathies]. Hautarzt (2008) 0.87
Relationship between the colour change of hydroxyapatite and the trace element manganese. Biomaterials (1993) 0.87
Histology of human alveolar bone regeneration with a porous tricalcium phosphate. A report of two cases. Clin Oral Implants Res (2001) 0.87
Induction and morphology of hydroxyapatite, precipitated from metastable simulated body fluids on sol-gel prepared silica. Biomaterials (1993) 0.87
In-vitro apatite formation on phosphorylated bamboo. J Mater Sci Mater Med (1997) 0.87
The ultrastructure of the bone-hydroxyapatite interface in vitro. J Biomed Mater Res (1992) 0.86
Osseous substance formation induced in porous calcium phosphate ceramics in soft tissues. Biomaterials (1994) 0.86
Calcium phosphate plasma-sprayed coatings and their stability: an in vivo study. J Biomed Mater Res (1994) 0.86
Guinea pig and rabbit model for the histological evaluation of permanent percutaneous implants. Biomaterials (1988) 0.86
The effect of denaturing agents on the molecular weight of bovine alpha-crystallin. Biochim Biophys Acta (1969) 0.86
Chewing ability as a parameter for evaluating the disability of patients with temporomandibular disorders. J Oral Rehabil (2001) 0.86
Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range. Clin Oral Implants Res (2000) 0.86
Preparation and characterization of electrodeposited calcium phosphate/chitosan coating on Ti6Al4V plates. J Dent Res (2004) 0.85
G7c, a novel gene in the mouse and human major histocompatibility complex class III region, possibly controlling lung tumor susceptibility. Immunogenetics (2000) 0.85
Dental implants in the atrophic maxilla: measurements of patients' satisfaction and treatment experience. Clin Oral Implants Res (1998) 0.85
Immediate dental root implants from synthetic dense calcium hydroxylapatite. J Prosthet Dent (1979) 0.85
Fibroblast and epithelial cell interactions with surface-treated implant materials. Biomaterials (1991) 0.85
Churg Strauss syndrome--successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment. Clin Exp Rheumatol (2004) 0.85